This website uses cookies to improve your experience. Continue if you are OK with this or read more in our privacy policy. 

AstraZeneca loses Seroquel appeal


The UK Court of Appeal has upheld the High Court’s decision that AstraZeneca’s patent for a sustained release formulation of anti-psychotic drug quetiapine is invalid.

AstraZeneca, Seroquel, Hexal, drug formulation, dosage


Payment types accepted